Press Releases

All Releases
Aug 03, 2022
AngioDynamics to Present at the Canaccord Genuity Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 3, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today
May 16, 2022
AngioDynamics to Present at the UBS Global Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--May 16, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today
May 03, 2022
AngioDynamics to Present at the BofA Securities Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--May 3, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today
Apr 04, 2022
AngioDynamics to Present at the Needham Virtual Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 4, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system and improving quality of life for patients, today announced that Jim Clemmer , President
Mar 08, 2022
AngioDynamics to Present at Three Investor Conferences in March
LATHAM, N.Y. --(BUSINESS WIRE)--Mar. 8, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and
Jan 03, 2022
AngioDynamics to Present at the Needham Virtual Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jan. 3, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and
Displaying 1 - 20 of 700